NASDAQ

Prime Medicine, Inc. (PRME)

♥ 672 Thanks from members

Live price chart, market sentiment, and community perspectives for Prime Medicine, Inc. (NASDAQ: PRME).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: David LiuFounder: Keith JoungFounder: Andrew AnzaloneLeadership: Sir David Liu (Co-founder and Scientific Advisory Board Chair)Leadership: Cameron Turtle (CEO)Holder: Arch Venture PartnersHolder: FMR LLCHolder: GVPrime editing platformTherapeutics for genetic diseasesIn vivo and ex vivo gene editing#PRME#Prime Medicine#prime editing#gene therapy#crispr biotech